Nephroprotective Potential of Human Albumin Infusion: A Narrative Review

Figure 1

Reduction in the frequency of occurrence of acute kidney injury and death in volume therapy with hyperoncotic human albumin (20% or 25%) compared to control treatment with hypooncotic solution (crystalloids, 4% or 5% human albumin solution) or no infusion. OR, odds ratio; CI, confidence interval. Data are from Wiedermann et al. [43].